Decent growth, benign inflation, a dovish Fed and a weaker dollar all favor equities but international and emerging stocks look set to build on the outperformance of the last year
www.marketwatch.com
#JPMorgan #international #stock #story #legs
Related Posts

Daily Spotlight: Yellow Metal in Demand
Daily Spotlight: Yellow Metal in Demand finance.yahoo.com #Daily #Spotlight #Yellow #Metal #Demand Related reading:If You Want Commodity Exposure Without Futures…

Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today
Clinical-stage biotech Protagonist Therapeutics (NASDAQ: PTGX) was all the rage on the stock market Friday. The company’s share price closed…

What High-Income Earners Need To Know
After a year of market swings and slowly creeping inflation, high-income earners will see a subtle but costly change in…

